ipamorelin is a ghrp CJC-1295 (No DAC) + + GHRP-2 (Blend) Ipamorelin vs GHRP-2 vs GHRP-6

Federal Register PCAC Notice of Meeting, published April 16, 2026 (docket FDA-2025-N-6895) FDA Pharmacy Compounding Advisory Committee meeting materials and minutes FDA 503A bulk drug substances category list (updated May 14, 2026) Contemporaneous coverage (secondary)

This is a strategy that also works well for managing tirzepatide tolerance and navigating semaglutide adjustments

Curious how they help

WADA and Athletic Testing The World Anti-Doping Agency (WADA) includes IGF-1 and all of its analogs (LR3, DES, etc.) on the Prohibited List under section S2: Peptide Hormones, Growth Factors, and Related Substances